Overview

PET Synaptogenesis After Psilocybin In DEpression Recovery

Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
Participants with depression will be given a single dose of psilocybin and supportive psychotherapy before, during, and after drug administration. Participants will undergo positron emission tomography (PET) imaging before and one week after psilocybin using a marker of synaptic density. This design allows us to assess the relationship between neurotrophic, and antidepressant effects produced by psilocybin.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Psilocybin